Skip to main content
. 2023 Jan 11;12(2):287. doi: 10.3390/cells12020287

Figure 5.

Figure 5

NanoBRET in-cell target engagement of CAMKK2 probe (5) (n = 3) and STO-609 (n = 1) in HEK293 cells transiently transfected with NLuc-CAMKK2. Increasing doses of inhibitor displaces the fluorescent inhibitor ligand (called a tracer) used in the assay, leading to a reduction in the BRET signal.